Page results
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
The latest copy of our magazine, Charity Matters is out now, available to read online or in hard copy in and around sites at UCLH hospitals.
-
Zero carbon, virtual appointments, specialist advice in primary care settings, thousands using online services, remote monitoring and digitising admin tasks: these are just some of the ways we will achieve patient-centred, integrated, excellent care for our patients as set out in our new outpatient strategy.
-
How we use your information at UCLH: what you need to know.
-
This information explains what you can expect from your care at the AL Amyloidosis Treatment Centre.
-
This page explains what extravasation is, and outlines the steps we take when it occurs.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
This page has been written to tell you more about an outpatient hysteroscopy, why it is being done and what it involves.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
Macmillan Support and Information Service offer emotional support, advice and information to people affected by cancer and blood conditions.
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma